A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MAO / metabolically abnormal obese

[Related PubMed/MEDLINE]
Total Number of Papers: 38
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MAO  (>> Co-occurring Abbreviation)
Long Form:   metabolically abnormal obese
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Correlates of and Body Composition Measures Associated with Metabolically Healthy Obesity Phenotype in Hispanic/Latino Women and Men: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL). HCHS/SOL, MHO, SD
2018 Changes in obese metabolic phenotypes over time and risk of incident chronic kidney disease. CKD, HR, MA, MANO, MHNO, MHO
2018 Mother's obesity and high child's waist circumference are predictive factors of severe child's obesity: an observational study in French Guiana. MNO, WtHR
2018 Role of adiponectin gene variants, adipokines and hydrometry-based percent body fat in metabolically healthy and abnormal obesity. HMW, LMW, MHO, PBF
2018 Whole-genome transcriptomic insights into protective molecular mechanisms in metabolically healthy obese African Americans. ER, MHO, RPs, TG/HDL
2017 Apolipoproteins A-I, B, and C-III and Obesity in Young Adult Cherokee. MHO
2017 Association between Sleep Habits and Metabolically Healthy Obesity in Adults: A Cross-Sectional Study. BMI, MHO
2017 Metabolic unhealthiness is an important predictor for the development of advanced colorectal neoplasia. AN, CI, HR, MANO, MHNO, MHO
10  2017 The prevalence, metabolic risk and effects of lifestyle intervention for metabolically healthy obesity: a systematic review and meta-analysis: A PRISMA-compliant article. CI, MA, MHNW, MHO, RRs
11  2016 Association between Obese Phenotype and Mildly Reduced eGFR among the General Population from Rural Northeast China. eGFR, MANO, MHNO, MHO
12  2016 Hepatic fat content is a determinant of metabolic phenotypes and increased carotid intima-media thickness in obese adults. AUC, CIMT, IHTG, MHO
13  2016 Impact of Parity on Body Size Phenotype in Postmenopausal Women: KNHANES 2010-2012. CI, OR
14  2016 Large adipocytes function as antigen-presenting cells to activate CD4(+) T cells via upregulating MHCII in obesity. FACS, FFA, IFN, MHC-II
15  2016 Obesity, metabolic abnormality, and health-related quality of life by gender: a cross-sectional study in Korean adults. HRQoL, MANW, MHO
16  2015 Association between body size phenotype and sleep duration: Korean National Health and Nutrition Examination Survey V (KNHANES V). BMI, KNHANES V, MANW, MHNW, MHO
17  2015 Healthy eating index and metabolically healthy obesity in U.S. adolescents and adults. BMI, HDL-C, HEI-2005, MHO, NHANES
18  2015 Metabolically normal obese people are protected from adverse effects following weight gain. apoB100, IHTG, MNO
19  2015 Obesity, metabolic abnormality, and knee osteoarthritis: a cross-sectional study in Korean women. MANW, MHNW, MHO
20  2015 Role of Fitness in the Metabolically Healthy but Obese Phenotype: A Review and Update. CRF, MHO, PF
21  2015 The metabolome profiling and pathway analysis in metabolic healthy and abnormal obesity. BMI, GPC, MHO
22  2015 Visceral and subcutaneous adipose tissue FDG uptake by PET/CT in metabolically healthy obese subjects. MHL, MHO, SAT
23  2014 A community-based exercise intervention transitions metabolically abnormal obese adults to a metabolically healthy obese phenotype. MHO
24  2014 Association of metabolically abnormal but normal weight (MANW) and metabolically healthy but obese (MHO) individuals with arterial stiffness and carotid atherosclerosis. BMI, MANW, MHNW, MHO, OR
25  2014 Differences in insulin clearance between metabolically healthy and unhealthy obese subjects. MHO
26  2014 Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy. IGT, MHO, T2D, VAT
27  2014 Metabolic abnormalities, but not obesity, contribute to the mildly reduced eGFR in middle-aged and elderly Chinese. BMI, eGFR, MANO, MHNO, MHO, ORs, WC
28  2014 Metabolically healthy obese subjects are at risk of fatty liver but not of pre-clinical atherosclerosis. CT, CVD, MANO, MHNO, MHO, ORs
29  2014 The metabolically healthy but obese phenotype is associated with lower plasma levels of persistent organic pollutants as compared to the metabolically abnormal obese phenotype. MHO, POPs
30  2013 A weight loss diet intervention has a similar beneficial effect on both metabolically abnormal obese and metabolically healthy but obese premenopausal women. MHO
31  2013 Body size phenotypes and low muscle mass: the Korean sarcopenic obesity study (KSOS). KSOS, MANW, MHNW, MHO
32  2013 Liver enzymes and vitamin D levels in metabolically healthy but obese individuals: Korean National Health and Nutrition Examination Survey. BMI, MHO
33  2013 Metabolically obese status with normal weight is associated with both the prevalence and severity of angiographic coronary artery disease. CAD, CI, DM, MHNW, MHO, MO, MONW, MONW, OR
34  2013 Prevalence of metabolically discordant phenotypes in a mediterranean population-The IMAP study. MANW, MAOW, MHNW, MHO, MHOW
35  2012 Unacylated Ghrelin is associated with the isolated low HDL-cholesterol obese phenotype independently of insulin resistance and CRP level. HDL-C, LHO, MHO
36  2010 Effects of weight loss among metabolically healthy obese men and women. MHO
37  2006 Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. CRP, LDL, MHO
38  2001 What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? MNO